Mette Kalager on Evidence in Endoscopy part 2: Which evidence beyond randomized trials in endoscopy?

Mette Kalager on Evidence in Endoscopy Part 1: Why are randomized trials the gold standard? What are the pros and cons, and what are the hiccups?

Colorectal ESD; this is part 1 - listen to super-expert Jeremie Jacques what you need to start, indications, lesion characterization, equipment and more

If you want to know everything about Barrett's esophagus, Roos Pouw is one of the people to ask - she is the General Secretary Elect of the UEGW. Learn about her professional development and other topics in this conversation

We have had many brilliant and detailed episodes about colonic EMR in various situation with Master Bourke - we guess you also want to know who is the person Michael Bourke? 

Adenoma detection rate (ADR) is a well established outcome quality parameter for (screening) colonoscopy since it is correlated with the interval cancer rate; however it is not known whether this correlation is linear or whether there is a cut-off, above which the effects on interval cancers do not get bigger any more. This new paper released today with Nastazja Pilonis as lead author tells you which assumption is more likely based on the large Polish screening colonoscopy database

Stefan Seewald explains different polyp classification systems using the most recent Olympus technologies and how new instruments help with differenting polyp types

Axel Dignaß as guest editor speaks with Timo Rath about innovations in endoscopic imaging in inflammatory bowel disease

Focusing on new endoscopic technology, Stefan Seewald shows fascinating examples of how to find very early and minute gastric cancer

In our second episode introducing editors of the big GI journals - we continue with the David Weinberg who works in Philadelphia; his research centers on the prevention and control of gastrointestinal malignancies